Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00248690
Status:
COMPLETED
Last Update Posted:
2011-01-19
First Post:
2005-10-25
Brief Title:
ICP Versus Intracranial Compliance Guided Management in SAH
Sponsor:
Oslo University Hospital
Organization:
Oslo University Hospital
Study Overview
Official Title:
Intracranial Pressure ICP Versus Intracranial Compliance ICC Guided Management in Subarachnoid Hemorrhage - a Prospective Randomized Trial
Status:
COMPLETED
Status Verified Date:
2008-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether treatment guided also by ICP mean wave amplitude improves outcome compared to international standard care in patients with SAH
Detailed Description:
In this study SAH-patients are randomized to treatment based on international standard care ICPCPP guided therapy or intracranial compliance ICP mean wave amplitude guided therapy in addition to ICPCPP guided therapy Main outcome variables are survival and neurological outcome after 3 and 12 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| S-05184 | None | None | None |